Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
dc.contributor.author | Swanson, Kena A. | |
dc.contributor.author | Polack, Fernando P. | |
dc.contributor.author | Thomas, Stephen J. | |
dc.contributor.author | Kitchin, Nicholas | |
dc.contributor.author | Absalon, Judith | |
dc.contributor.author | Gurtman, Alejandra | |
dc.contributor.author | Lockhart, Stephen | |
dc.contributor.author | Perez, John L. | |
dc.contributor.author | Perez Marc, Gonzalo | |
dc.contributor.author | Moreira, Edson D. | |
dc.contributor.author | Zerbini, Cristiano | |
dc.contributor.author | Bailey, Ruth | |
dc.contributor.author | Roychoudhury, Satrajit | |
dc.contributor.author | Koury, Kenneth | |
dc.contributor.author | Li, Ping | |
dc.contributor.author | Kalina, Warren V. | |
dc.contributor.author | Cooper, David | |
dc.contributor.author | Frenck, Robert W. | |
dc.contributor.author | Hammitt, Laura L. | |
dc.contributor.author | Tureci, Ozlem | |
dc.contributor.author | Nell, Haylene | |
dc.contributor.author | Schaefer, Axel | |
dc.contributor.author | Unal, Serhat | |
dc.contributor.author | Tresnan, Dina B. | |
dc.contributor.author | Mather, Susan | |
dc.contributor.author | Dormitzer, Philip R. | |
dc.contributor.author | Sahin, Ugur | |
dc.contributor.author | Jansen, Kathrin U. | |
dc.contributor.author | Gruber, William C. | |
dc.date.accessioned | 2021-12-10T09:36:59Z | |
dc.date.available | 2021-12-10T09:36:59Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Polack F. P. , Thomas S. J. , Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J. L. , Perez Marc G., Moreira E. D. , Zerbini C., et al., "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine", NEW ENGLAND JOURNAL OF MEDICINE, cilt.383, sa.27, ss.2603-2615, 2020 | |
dc.identifier.issn | 0028-4793 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_073bc193-1e40-4922-8095-18d92477fad8 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/168109 | |
dc.identifier.uri | https://doi.org/10.1056/nejmoa2034577 | |
dc.description.abstract | BACKGROUND | |
dc.language.iso | eng | |
dc.subject | General Medicine | |
dc.subject | Health Sciences | |
dc.subject | Pathophysiology | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Family Practice | |
dc.subject | Fundamentals and Skills | |
dc.subject | General Health Professions | |
dc.subject | Internal Medicine | |
dc.subject | Assessment and Diagnosis | |
dc.subject | Medicine (miscellaneous) | |
dc.title | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | |
dc.type | Makale | |
dc.relation.journal | NEW ENGLAND JOURNAL OF MEDICINE | |
dc.contributor.department | Fdn INFANT , , | |
dc.identifier.volume | 383 | |
dc.identifier.issue | 27 | |
dc.identifier.startpage | 2603 | |
dc.identifier.endpage | 2615 | |
dc.contributor.firstauthorID | 2605457 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Makale [92796]